comparemela.com
Home
Live Updates
Professor Ji Jiafu - Breaking News
Pages:
Latest Breaking News On - Professor ji jiafu - Page 1 : comparemela.com
Supplemental New Drug Application for Akeso s Cadonilimab (PD-1/CTLA-4) Accepted by NMPA for First-line Treatment of Gastric Cancer
/PRNewswire/ Akeso (9926.HK) announced the China National Medical Products Administration (NMPA) has accepted the supplemental new drug application (sNDA).
Lin shen
Hong kong
Ji jiafu
Yu xia
Akeso inc
China national medical products administration
University cancer hospital
Professor ji jiafu
Peking university cancer
Professor lin shen
Summit therapeutics
Main board
Stock exchange
Patient Enrollment Completed for Phase III Clinical Trial of Akeso s Cadonilimab in Treatment of Gastric Cancer
/PRNewswire/ Akeso, Inc. (9926.HK) announced that patient enrollment has been completed for its pivotal Phase III clinical trial for cadonilimab.
Ji jiafu
Prnewswire akeso inc
Akeso inc
Professor ji jiafu
Peking cancer hospital
vimarsana © 2020. All Rights Reserved.